Spots Global Cancer Trial Database for ICI-VPH: Impact of HPV Immunisation Schedules Against HPV
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: ICI-VPH: Impact of HPV Immunisation Schedules Against HPV
Official Title: ICI-VPH: Impact Des Calendriers d'Immunisation Contre Les HPV
Study ID: NCT02009800
Conditions
Interventions
Study Description
Brief Summary: This randomised clinical trial aims to determine whether an immunization schedule comprising two doses of Gardasil administered six months apart is non-inferior to a schedule comprising three doses administered at 0, 6 and 60 months for the prevention of HPV-16 and HPV-18 infections that persist for at least six months, up to ten years after the initial vaccination. The study hypothesis is that the two-dose schedule would offer similar protection as that of a three-dose schedule against persistent HPV-16/18 infections.
Detailed Description:
Keywords
Eligibility
Minimum Age: 14 Years
Eligible Ages: CHILD
Sex: FEMALE
Healthy Volunteers: Yes
Locations
Centre Hospitalier Uiversitaire de Montréal, Montréal, Quebec, Canada
Centre Hospitalier Universitaire de Québec, CHU de Québec, Québec, , Canada
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
